-
2081“…Chronic infection with the hepatitis C virus (HCV) is a cause of cirrhosis and hepatocellular carcinoma worldwide. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2082“…Hepatitis C virus (HCV) usurps host cellular lipid metabolism for production of infectious virus particles. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2083“…Recent advances in the treatment of hepatitis C virus (HCV) infection have led to the availability of both highly efficacious interferon-containing and interferon-sparing regimens. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2084“…Clinically, triple therapy with PEG-IFNα/RBV together with direct-acting antiviral agents (DAAs) is currently used to treat chronic hepatitis C as a first-line therapy. Although the predictive power of IL28B status may be attenuated, the IL28B genotype will remain relevant to the outcomes of DAA therapy when used in combination with PEG-IFNα as a backbone. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2085por Hahm, Ki Baik, Chon, Chae Yoon, Kim, Won Ho, Han, Kwang Hyub, Chung, Jae Bock, Lee, Sang In, Moon, Young Myung, Kang, Jin Kyung, Park, In Suh, Choi, Heung Jai, Han, Eun Kyung, Park, Chan Il“…Reports on the histologic findings of chronic active hepatitis C (CAH-C) have been rare, and the characteristic histologic findings of CAH-C have been not yet determined. …”
Publicado 1992
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2086por Ezzikouri, Sayeh, Kimura, Kiminori, Sunagozaka, Hajime, Kaneko, Shuichi, Inoue, Kazuaki, Nishimura, Tomohiro, Hishima, Tsunekazu, Kohara, Michinori, Tsukiyama-Kohara, Kyoko“…BACKGROUND: New biomarkers are needed to identify the stage of hepatitis C virus (HCV)-infected diseases in order to reduce the mortality rates. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2087por Hashemi, Farnaz, Fathi Ashtiani, Ali, Mirminachi, Babak, Sharafkhah, Maryam, Ekhlasi, Golnaz, Jafari, Elham, Poustchi, Hossein“…Cognitive function of hepatitis C virus (HCV) patients was significantly impaired, with respect to logical memory, visual reproduction and MQ score, compared to other underlying causes of cirrhosis (P = 0.01, P = 0.04, and P = 0.01, respectively) CONCLUSIONS: Our results suggested that neuropsychiatric and cognitive problems must be considered in the management of covert hepatic encephalopathy (HE) patients, especially in patients with HCV infection. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2088por Retamozo, Soledad, Díaz-Lagares, Cándido, Bosch, Xavier, Bové, Albert, Brito-Zerón, Pilar, Gómez, Maria-Eugenia, Yagüe, Jordi, Forns, Xavier, Cid, Maria C., Ramos-Casals, Manuel“…Cryoglobulinemia is characterized by a wide range of causes, symptoms, and outcomes. Hepatitis C virus (HCV) infection is detected in 30%–100% of patients with cryoglobulins. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2089
-
2090por Iles, James C., Njouom, Richard, Foupouapouognigni, Yacouba, Bonsall, David, Bowden, Rory, Trebes, Amy, Piazza, Paolo, Barnes, Ellie, Pépin, Jacques, Klenerman, Paul, Pybus, Oliver G.“…The importance of recombination in the evolution and genetic diversity of the hepatitis C virus (HCV) is currently uncertain. Only a small number of intergenotypic recombinants have been identified so far, and each has core and envelope genes classified as belonging to genotype 2. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2091por Nielsen, Mette J., Kazankov, Konstantin, Leeming, Diana J., Karsdal, Morten A., Krag, Aleksander, Barrera, Francisco, McLeod, Duncan, George, Jacob, Grønbæk, Henning“…METHODS: Specific protein fragments of matrix metalloprotease degraded type I, III, IV and VI collagen (C1M, C3M, C4M, C6M) and type III and IV collagen formation (Pro-C3 and P4NP7S) were assessed in plasma from 403 chronic hepatitis C patients by specific ELISAs. Patients were stratified according to Metavir Fibrosis stage; F0 (n = 46), F1 (n = 161), F2 (n = 95), F3 (n = 44) and F4 (n = 33) based on liver biopsy. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2092“…OBJECTIVE: To determine compliance and improvement in sustained viral response (SVR) by following response guided therapy (RGT) plan of interferon and ribavirin, for genotype 3 in chronic hepatitis C. METHODS: Patients with chronic hepatitis C genotype 3, who were eligible for interferon-ribavirin therapy and consented for RGT, were included. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2093por Zuchowski, Jessica L., Hamilton, Alison B., Pyne, Jeffrey M., Clark, Jack A., Naik, Aanand D., Smith, Donna L., Kanwal, Fasiha“…BACKGROUND: In this era of a constantly changing landscape of antiviral treatment options for chronic viral hepatitis C (CHC), shared clinical decision-making addresses the need to engage patients in complex treatment decisions. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2094por Smirnova, Irina S., Aksenov, Nikolai D., Kashuba, Elena V., Payakurel, Pawan, Grabovetsky, Vadim V., Zaberezhny, Alexei D., Vonsky, Maxim S., Buchinska, Lubov, Biberfeld, Peter, Hinkula, Jorma, Isaguliants, Maria G.“…The oncogenic potential of hepatitis C virus (HCV) core protein has been demonstrated, but the precise mechanism of cell transformation triggered by HCV core is still unclear. …”
Publicado 2006
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2095por Yang, Zhen, Yu, Yongxin, Zhang, Hongzhong, Shang, Guifang, Gao, Jialiang, Jiang, Jian-Dong, Peng, ZonggenEnlace del recurso
Publicado 2014
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2096por Wilson, Garrick K., Farquhar, Michelle J., Meredith, Luke, Dhawan, Anil, Mitry, Ragai, Balfe, Peter, McKeating, Jane A.“…The major cell type supporting hepatitis C virus (HCV) infection is the hepatocyte; however, most reports studying viral entry and replication utilize transformed hepatoma cell lines. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2097por Alonso, Monica, Gutzman, Annika, Mazin, Rafael, Pinzon, Carlos E., Reveiz, Ludovic, Ghidinelli, Massimo“…OBJECTIVES: Summarize hepatitis C virus (HCV) prevalence in injecting (IDU) and non-injecting drug users (NIDU), men who have sex with men (MSM), sex workers, and prison inmates in Latin America and the Caribbean (LAC). …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2098“…Treating alcohol use disorders (AUD) is critical in individuals suffering from hepatitis C infection (HCV). Aside from psychosocial interventions, pharmacological treatment is effective for decreasing alcohol consumption and promoting abstinence. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2099por Sominskaya, Irina, Jansons, Juris, Dovbenko, Anastasija, Petrakova, Natalia, Lieknina, Ilva, Mihailova, Marija, Latyshev, Oleg, Eliseeva, Olesja, Stahovska, Irina, Akopjana, Inara, Petrovskis, Ivars, Isaguliants, MariaEnlace del recurso
Publicado 2015
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2100por Anthony, Kevin, Subramanya, Gitanjali, Uprichard, Susan, Hammouda, Faiza, Saleh, Mahmoud“…More recently, silymarin has also been identified as a possible antiviral for the treatment of hepatitis C virus (HCV) infection. To assess different brands of commercially sold silymarin, 45 products were collected from local stores and analyzed for their silymarin content, antioxidant activities, and antiviral activity against HCV. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto